药学监护在联合吸入疗法治疗慢性阻塞性肺疾病患者的应用

目的评价药学监护在联合吸入疗法治疗慢性阻塞性患者的影响。方法选取笔者所在医院2013-01~09间所收治的90例慢性阻塞性肺疾病血瘀型患者的临床诊治资料,根据住院单双号分为观察组和对照组2组。对照组给与一般观察,观察组由临床药师主导药学干预。考察指标包括气血分析、血液流变学指标测定、定期测试肺功能以及用药依从性。结果与对照组相比,观察组患者的治疗结果中的治愈率明显优于对照组（P〈0.01）,用药依从性显著增高（P〈0.05）,肝功能也显著提高（P〈0.05）。结论临床药师对在联合吸入疗法治疗慢性阻塞性肺疾病患者进行全程化的药学干预,可改善患者的治疗效果、用药依从性、满意度,但药物不良事件的发生率差异无显著性。

Pharmaceutical Care in United Inhalation Rreatment for Patients with Chronic Obstructive Pulmonary Disease

Objective To evaluate the pharmaceutical care in the joint effects of patients with chronic obstructive inhalation therapy treatment. Methods The clinical diagnosis and treatment information of 90 patients with chronic obstructive pulmonary disease and blood stasis in the hospital between January to September 2013 were collected. The patients were divided into observation group and control group according to their hospitalization date. Patients in the control group were given the general observation, while patients in the observation group dominated by clinical pharmacists pharmaceutical intervention. The examining indexes included blood analysis and blood rheology indexes determination, regularly lung function test and medication adherence. Results Compared with control group, the cure rate of patients in the observation group was significantly better than that of control group （ P〈0.O1 ） ; medication adherence was significantly higher （P〈0.05） ; liver function was also significantly increased （P〈0.05）. Conclusion Clinical pharmacists to joint inhalation therapy in the treatment of chronic obstructive pulmonary disease patients thorough pharmaceutical intervention can improve the therapeutic effect of patients, medication compliance, satisfaction of the patients, but there was no significant difference in the incidence of adverse drug events.